Results 1 to 10 of about 306,493 (74)

NOACs: drug–drug interactions [PDF]

open access: yesCanadian Medical Association Journal, 2016
We commend Fralick and colleagues for their article on drug interactions with rivaroxaban.[1][1] All novel oral anticoagulants (NOACs) were introduced as at least noninferior (in some cases superior) to warfarin.
Mariusz Gasior   +2 more
openaire   +2 more sources

Two-dimensional three-body quadrupole-quadrupole interactions [PDF]

open access: yes, 2021
Similar to interactions between dipoles, or van der Waals interactions, quadrupole-quadrupole interactions are interactions between quadrupoles. In this article, we study the quadrupole interactions between highly excited atoms or Rydberg atoms. In addition, unlike many other calculations, in which the primary focus was on the one-dimensional two-body ...
arxiv   +1 more source

DeepSI: Interactive Deep Learning for Semantic Interaction [PDF]

open access: yesIUI '21: 26th International Conference on Intelligent User Interfaces, College Station, TX, USA, April 2021, 2023
In this paper, we design novel interactive deep learning methods to improve semantic interactions in visual analytics applications. The ability of semantic interaction to infer analysts' precise intents during sensemaking is dependent on the quality of the underlying data representation.
arxiv   +1 more source

Transferable Interactiveness Knowledge for Human-Object Interaction Detection [PDF]

open access: yesIEEE Transactions on Pattern Analysis and Machine Intelligence, 2021, 2021
Human-Object Interaction (HOI) detection is an important problem to understand how humans interact with objects. In this paper, we explore interactiveness knowledge which indicates whether a human and an object interact with each other or not. We found that interactiveness knowledge can be learned across HOI datasets and bridge the gap between diverse ...
arxiv   +1 more source

Pharmacodynamic Drug–Drug Interactions [PDF]

open access: yesClinical Pharmacology & Therapeutics, 2019
Pharmacodynamic drug–drug interactions (DDIs) occur when the pharmacological effect of one drug is altered by that of another drug in a combination regimen. DDIs often are classified as synergistic, additive, or antagonistic in nature, albeit these terms are frequently misused.
Robert M. Straubinger   +2 more
openaire   +2 more sources

Drug-drug interactions of tacrolimus [PDF]

open access: yesHospital Pharmacology - International Multidisciplinary Journal, 2015
Introduction: Tacrolimus, potent immunosupressive drug, has large inter- and intraindividual pharmacokinetic variability. The aim: The aim of this current topic is to describe the importance of tacrolimus drug-drug interactions. Pharmacokinetic interactions between tacrolimus and other drugs: Concerning the fact that it is also a medicine with the ...
Neven Vavic   +4 more
openaire   +3 more sources

Drug-drug interactions in the ICU [PDF]

open access: yesCritical Care, 2009
The present study intended to identify and analyze the significance of drug–drug interaction (DDI) in critically ill patients.
S Ray   +3 more
openaire   +2 more sources

Multi-Relation Aware Temporal Interaction Network Embedding [PDF]

open access: yesarXiv, 2021
Temporal interaction networks are formed in many fields, e.g., e-commerce, online education, and social network service. Temporal interaction network embedding can effectively mine the information in temporal interaction networks, which is of great significance to the above fields.
arxiv  

Optimizing higher-order network topology for synchronization of coupled phase oscillators [PDF]

open access: yesarXiv, 2021
Networks in nature have complex interactions among agents. One significant phenomenon induced by interactions is synchronization of coupled agents, and the interactive network topology can be tuned to optimize synchronization. The previous studies showed that the optimized conventional network with pairwise interactions favors a homogeneous degree ...
arxiv  

A Review of Daclatasvir Drug–Drug Interactions [PDF]

open access: yesAdvances in Therapy, 2016
The treatment of hepatitis C virus (HCV) infection has been revolutionized in recent years by the development of direct-acting antiviral regimens that do not contain peginterferon (pegIFN) and/or ribavirin (RBV). While direct-acting antiviral-based regimens have been shown to be greatly superior to pegIFN/RBV-based regimens in terms of efficacy and ...
Shu-Pang Huang   +7 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy